GeneDx Holdings Corp.WGSNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank83
3Y CAGR+306.8%
5Y CAGR-5.6%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+306.8%/yr
Annual compound
5Y CAGR
-5.6%/yr
Recent acceleration
Percentile
P83
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
20258.29+20.7%
20246.87+1500.1%
20230.43+248.6%
20220.12-77.1%
20210.54-95.1%
202011.07-
20190.00-